Clinical trial
Prozac Treatment of Major Depression: Discontinuation Study
NCT00427128 · New York State Psychiatric Institute, Other · Completed
Key facts
| NCT number | NCT00427128 |
|---|---|
| Title | Prozac Treatment of Major Depression: Discontinuation Study |
| Official title | Prozac Treatment of Major Depression: Discontinuation Study |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | Massachusetts General Hospital |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Major Depression |
| Intervention type | Drug |
| Interventions | fluoxetine, placebo |
| Enrollment | 627 |
| Start date | Nov 1, 1995 |
| Completion | Mar 1, 2003 |
| First posted | Jan 26, 2007 |
| Last update posted | Dec 15, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: